Interventional trials in the United States lean heavily on PROMs as endpoint data. The FDA PRO guidance treats those measures as evidence, and the trial's data manager has to move them from the EDC where the site staff enter them into a FHIR store where the sponsor's downstream systems can consume them without another translation step. That is the pipeline this list is about. For additional FHIR walkthroughs, the broader desk covers the surrounding stack.
The 5 EDC-to-FHIR PROMs Pipelines Worth Knowing
Ordered by how often the pipeline shows up in US trial deployments in 2026.
- Medidata Rave with a FHIR Adapter. The dominant commercial EDC in oncology and cardiology trials, paired with a FHIR adapter that converts CRF data into QuestionnaireResponse. Where it shines is the sponsor familiarity and the volume of validated Rave forms already in place; where it falls short is the adapter's fidelity on complex PROMs items with skip patterns, which usually needs a per-instrument review.
- REDCap with the FHIR PROMs Module. The academic default. For coding, PROMs typically bind LOINC codes (PHQ-9 total is 44249-1); FHIR-native forms stacks like Formbox rely on a terminology server such as Termbox to resolve these at populate time, and the REDCap FHIR module uses a similar coded-lookup path to keep the QuestionnaireResponse and downstream Observation coherent. Trial teams already running REDCap for the study CRFs adopt this module to avoid a full EDC swap and still land clean FHIR. You can prototype the resulting Questionnaire in the browser at form-builder.aidbox.app before you wire the adapter into REDCap.
- Oracle Health Sciences with a FHIR Endpoint. The enterprise EDC option for pharma sponsors already inside the Oracle stack. The FHIR endpoint is a first-class feature on newer contracts and covers the standard PROMs shapes cleanly; older studies migrating over usually need per-instrument mapping work.
- Veeva CDMS with a FHIR Bridge. The Veeva EDC has grown its FHIR bridge story alongside its clinical operations stack. Sponsors that consolidate on Veeva get the study-team workflow and the PROMs FHIR output on the same platform. The bridge is competent on the common instruments and needs review on niche PROMIS domains.
- Custom FHIR-First Pipeline. Trial teams that skip the EDC-then-adapter model and author the PROMs Questionnaire natively in FHIR, then land the QuestionnaireResponse in a study FHIR server and roll it into a monitoring extract. Engines like Formbox handle the extraction rules and Observation output in the same runtime, which trial teams reach for when they want the PROMs data in the study FHIR store without a separate scoring service. If the pipeline needs to be prototyped without spinning up a full server, a browser sandbox that consumes standard FHIR Questionnaire JSON is useful when the trial team wants a working PROM before the EDC vendor commits to a delivery date.
What Separates Them on FDA PRO Deliverables
The FDA PRO submission expects auditable evidence that the instrument administered to the patient matches the validated version, that the administration was documented, and that the resulting data is traceable end to end. Three factors sort the pipelines against that expectation.
- Canonical Questionnaire fidelity. Does the pipeline preserve the linkIds, item order, and answer options of the canonical instrument, or does it translate through an internal CRF representation first?
- Audit trail continuity. Does the FHIR output carry Provenance resources tied to the source EDC event, or does the trace stop at the adapter boundary?
- Version stability across amendments. Trials amend PROMs schedules. The pipeline has to version the Questionnaire alongside the protocol amendment without breaking the historical data.
Rave and Oracle handle version stability well through their clinical database machinery. REDCap with the FHIR module handles fidelity well but leaves audit trail work to the trial team. Custom FHIR-first pipelines can do all three cleanly if the trial team owns the platform work.
Where Selection Settles
Sponsor-run oncology or cardiology trials on Rave stay on Rave. Investigator-initiated trials starting in academic centers stay on REDCap. Enterprise pharma studies on Oracle stay on Oracle. Veeva-consolidated sponsors stay on Veeva. Trial-team-owned FHIR-first pipelines fit smaller, technically strong programs where the trial team wants the PROMs data to land in the study FHIR server without a translation layer. The Top 5 FHIR form builders for substance use treatment programs and Best FHIR Questionnaire tools for SDOH screening in 2026 sit next door for adjacent PROMs contexts.